Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 292241 - 292260 out of 566296 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Greece | (L01FD01) trastuzumab (adm: P) | KANJINTI® PD.C.SO.IN 150MG/VIAL BT x 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AMGENEUROPEBV,BREDA,HOLLAND |
| Greece | (L01FD01) trastuzumab (adm: P) | OGIVRI PD.C.S.INF 150MG BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BIOSIMILARCOLLABORATIONSIRELANDLIMITED,IRELAND |
| Greece | (L01FD01) trastuzumab (adm: P) | ONTRUZANT® PD.C.S.INF 150MG/VIAL BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | SAMSUNGBIOEPISNLB.V.,THENETHERLANDS |
| Greece | (L01FD01) trastuzumab (adm: P) | TRAZIMERA PD.C.SO.IN 150MG BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FD01) trastuzumab (adm: P) | ZERCEPAC PD.C.SO.IN 150MG/VIAL BTx 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | ACCORDHEALTHCARES.L.U.,SPAIN |
| Greece | (L01FD01) trastuzumab (adm: P) | HERZUMA PD.C.S.INF 420MG/VIAL BTx 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | CELLTRIONHEALTHCAREHUNGARYKFT.,BUDAPEST,HUNGARY |
| Greece | (L01FD01) trastuzumab (adm: P) | KANJINTI PD.C.SO.IN 420MG/VIAL BT x 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AMGENEUROPEBV,BREDA,HOLLAND |
| Greece | (L01FD01) trastuzumab (adm: P) | OGIVRI PD.C.S.INF 420MG/VIAL BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BIOSIMILARCOLLABORATIONSIRELANDLIMITED,IRELAND |
| Greece | (L01FD01) trastuzumab (adm: P) | ONTRUZANT® PD.C.S.INF 420MG/VIAL BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | SAMSUNGBIOEPISNLB.V.,THENETHERLANDS |
| Greece | (L01FD01) trastuzumab (adm: P) | ZERCEPAC PD.C.SO.IN 420MG/VIAL BTx 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | ACCORDHEALTHCARES.L.U.,SPAIN |
| Greece | (L01FD03) trastuzumab emtansine (adm: P) | KADCYLA PD.C.SO.IN 100MG BTx1VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FD03) trastuzumab emtansine (adm: P) | KADCYLA PD.C.SO.IN 160MG BTx1VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FD04) trastuzumab deruxtecan (adm: P) | ENHERTU PD.C.S.INF 100MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | DAIICHISANKYOEUROPEGMBH,MUNICH,GERMANY |
| Greece | (L01FF01) nivolumab (adm: P) | OPDIVO C/S.SOL.IN 10MG/ML BT X 1 VIAL X 12 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | BRISTOL-MYERSSQUIBBPHARMAEEIG,IRELAND |
| Greece | (L01FF03) durvalumab (adm: P) | IMFINZI C/S.SOL.IN 50MG/ML 1 vialx 2.4 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAAB,SOEDERTAELJE,SWEDEN |
| Greece | (L01FF03) durvalumab (adm: P) | IMFINZI C/S.SOL.IN 50MG/ML 1 vialx10 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAAB,SOEDERTAELJE,SWEDEN |
| Greece | (L01FF04) avelumab (adm: P) | BAVENCIO C/S.SOL.IN 20MG/ML BTx1 VIAL x 10ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MERCKEUROPEB.V.,THENETHERLANDS |
| Greece | (L01FF05) atezolizumab (adm: P) | TECENTRIQ C/S.SOL.IN 1200MG/VIAL (20ML) 1 VIAL x 20ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FF06) cemiplimab (adm: P) | LIBTAYO C/S.SOL.IN 350MG/VIAL BTx1 vial x7 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | REGENERONIRELANDDESIGNATEDACTIVITYCOMPANY(DAC),IRELAND |
| Greece | (L01FF07) dostarlimab | JEMPERLI C/S.SOL.IN 500MG/VIAL 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GLAXOSMITHKLINETRADINGSERVICESLIMITED,DUBLIN,IRELAND |
Pages
